Guest guest Posted November 18, 2010 Report Posted November 18, 2010 Dr. Kipps et al published in Blood, suggest that a kidney and liver drug sorafenib may have some effects in CLL. The abstract states: " The CXCL12-induced phosphorylation of ERK and MEK in ZAP-70+ CLL cells was blocked by sorafenib, a small molecule inhibitor of RAF. Furthermore, ZAP-70+ CLL cells were more sensitive than ZAP-70- CLL cells to the cytotoxic effects of sorafenib in vitro at concentrations that can readily be achieved in vivo. " Early, early days... ~chris Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.